Hourly refreshFri, Sep 4, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Finance

25,795 press releases indexed under finance.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Finance · Education

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

ST. LOUIS, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that the Electrophysiology team at the University of Szeged in Hungary has successfully treated over 70 patients using the Genesis Robotic Magnetic Navigation system, just over a month after launching its robotic cardiology program.

Sep 3 · 11:56GlobeNewswire
Finance

PROCEPT BioRobotics Corporation (PRCT) Investors: September 22, 2026 ...

(PR-inside.com) SAN FRANCISCO, CA / ACCESS Newswire / September 3, 2026 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ:PRCT) who purchased the common stock of Procept between February 28, 2024 and February 25, 2026, inclusive (the "Class Period") to contact us immediately regarding the pending securities class action against Procept. The deadline to apply to be lead plaintiff is September 22, 2026. Class Period: February 28, 2024 - February 25, 2026 Lead Plaintiff Motion Deadline: September 22, 2026 Case information: https://lieffcabraser.com/securities/procept/ Contact us: Email or text investorinfo@lchb.com or call 1-800-541-7358 Procept, headquartered ..

Sep 3 · 11:55PR-Inside
Finance

HYLN LAWSUIT ALERT: Levi & Korsinsky Notifies Hyliion Holdings Corp. ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Hyliion Holdings Corp. (NYSE:HYLN) securities. If you suffered a loss on your Hyliion investment and would like to explore a potential recovery under the federal securities laws, Learn about Hyliion Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Hyliion Holdings Corp. that ..

Sep 3 · 11:50PR-Inside
Finance · AI

3 E Network CEO Continues to Increase His Stake, Reflecting Confidence in the Company’s AI Strategy and Operational Results

3E Network CEO Continues to Increase His Stake, Reflecting Confidence in the Company’s AI Strategy and Operational Results

Sep 3 · 11:50GlobeNewswire
Finance · AI

AGM Group Holdings Inc.’s Full-Stack AI Storage Solutions Gain Traction, Expecting Significant Delivery Growth in H2 2026

AGMH expands AI infrastructure business with full-stack AI storage solutions, all-flash server production, and growing hardware delivery momentum in H2.

Sep 3 · 11:50GlobeNewswire
Finance

Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes

GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has completed the repurchase of $75 million aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028 (the “Senior Unsecured Notes”), following authorization granted by its Board of Directors. In total, Emergent deployed approximately $68 million of cash for the repurchases, resulting in an average repurchase price of 90.6% of face value. Following completion of the repurchases, the outstanding aggregate principal balance of the Senior Unsecured Notes has been reduced to approximately $364.7 million.

Sep 3 · 11:45GlobeNewswire
Finance · Energy

PowerBank Awarded Contract by New York Power Authority for 1.6 MW Ground-Mount Solar Project at SUNY Oneonta

Project expected to generate recurring energy revenue and qualify for approximately US$1.4 million in federal investment tax credits First MW-scale array to power campus facilities TORONTO, Sept. 3, 2026 /PRNewswire/ -- PowerBank Corporation (Nasdaq: PBK) (Cboe CA: PBK) (FSE: 103)...

Sep 3 · 11:45PR Newswire
Finance · AI

Lyken.AI Enters Non-Binding MOU with FingerMotion and BlueFlare to ...

(PR-inside.com) Framework positions Lyken as the customer-facing demand and managed-services layer for potential future capacity developed under FingerMotion's BlueFlare alliance VANCOUVER, BC / ACCESS Newswire / September 3, 2026 / Alset AI Ventures Inc. (TSXV:GPUS)(OTCQB:GPUSF)(FSE:1R61, WKN:A40M0J) ("Alset AI", "Alset" or the "Company"), an artificial intelligence ("AI") venture company advancing innovation through strategic investment and cloud computing solutions, is pleased to announce that its 90.1%-owned cloud compute business, Lyken AI Computing Inc., operating as Lyken.AI ("Lyken"), has entered into a non-binding strategic memorandum of understanding dated September 2, 2026 (the "MOU") with BlueFlare Energy Solutions Inc. ("BlueFlare") and FingerMotion, Inc. (NASDAQ:FNGR) ("Finge

Sep 3 · 11:30PR-Inside
Finance · Retail

Consumer Cybersecurity Pioneer Guardio Reaches $1.1 Billion Valuation

Guardio surpasses one million customers and $150 million ARR after four consecutive years of triple-digit growth TEL AVIV, Israel, Sept. 3, 2026 /PRNewswire/ -- Guardio, a leader in consumer cybersecurity, today announced it has reached a valuation of $1.1bn. This, following a funding...

Sep 3 · 11:30PR Newswire
Finance · Healthcare

Crescent Biopharma to Present at September Investor Conferences

WALTHAM, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in September:

Sep 3 · 11:30GlobeNewswire
Finance

Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting

- Data support the ongoing development of four investigational therapies for DMD amenable to skipping of exons 53, 45, 44 or 55, all of which are advancing into IND-enabling studies -

Sep 3 · 11:30GlobeNewswire
Finance · Healthcare

FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis

Liquidia (Nasdaq: LQDA): FDA grants Fast Track designation to YUTREPIA for systemic sclerosis-associated Raynaud's phenomenon; Phase 2a study in Q4 2026

Sep 3 · 11:30GlobeNewswire
← Prev1232150Next →